What is the appropriate management for a typical uncomplicated upper respiratory tract infection in otherwise healthy adults or children?

Management of Uncomplicated Upper Respiratory Tract Infections

Antibiotics should NOT be prescribed for uncomplicated viral URTIs, as 80–90% are viral, they provide no clinical benefit, and the number needed to harm (8) exceeds the number needed to treat (18). 1, 2

Symptomatic Treatment Approach

Use analgesics as first-line therapy for symptom control:

• Acetaminophen or NSAIDs (ibuprofen, naproxen) for headache, body aches, and fever 1, 3

For nasal congestion and rhinorrhea:

• Intranasal saline irrigation is first-line therapy—improves nasal airflow without adverse effects 1
• Systemic decongestants (pseudoephedrine) or topical decongestants (oxymetazoline) for short-term relief 1
• Limit topical decongestants to ≤3 days to prevent rebound congestion (rhinitis medicamentosa) 1
• Intranasal corticosteroids for persistent nasal symptoms with notable mucosal inflammation 1

For bothersome dry cough:

• Short course of cough suppressants (dextromethorphan or codeine) may be offered 2

Avoid ineffective agents:

• Do NOT prescribe expectorants, mucolytics, antihistamines, inhaled corticosteroids, or bronchodilators—they have no proven benefit for viral URTIs 2

Antibiotic Stewardship: When NOT to Prescribe

Purulent nasal discharge or green/yellow sputum does NOT indicate bacterial infection and should NOT trigger antibiotic therapy. 1, 2

Antibiotics do not:

• Shorten illness duration 1
• Reduce work-loss days 1
• Prevent complications 1

Macrolide antibiotics (azithromycin) should be avoided—they drive antimicrobial resistance and cause more adverse events than placebo. 2

Red-Flag Indicators for Bacterial Superinfection

Consider antibiotics ONLY when any of the following appear:

• Persistent symptoms >10 days without improvement 1, 2
• High fever (>39°C) with purulent nasal discharge for ≥3 consecutive days 1, 2
• "Double sickening"—initial improvement followed by worsening between days 5–7 1, 2
• Development of acute otitis media, acute bacterial sinusitis, or streptococcal pharyngitis 1

For suspected acute bacterial rhinosinusitis meeting above criteria:

• Amoxicillin is first-line therapy 2
• Amoxicillin-clavulanate for β-lactamase producers or treatment failure 2

For suspected streptococcal pharyngitis:

• Confirm diagnosis with rapid antigen detection test (RADT) or throat culture before prescribing 2
• Amoxicillin for 10 days if confirmed 2

Patient Counseling on Expected Course

Inform patients that most symptoms resolve within 7–10 days, with greatest improvement during the first week. 1, 4

Symptom duration up to 2 weeks remains within normal viral trajectory and does NOT necessitate antibiotics. 1, 4

Advise patients to seek further evaluation if:

• Fever lasting >3 days or recurring after initial improvement 1
• Symptoms persisting >10 days without any sign of improvement 1
• Emergence of severe signs (high fever >39°C with purulent discharge for ≥3 days) 1
• "Double sickening" pattern (worsening after initial improvement) 1

Special High-Risk Populations

Lower threshold for antibiotics in:

• Adults >75 years with fever 2
• Cardiac failure 2
• Insulin-dependent diabetes mellitus 2
• Serious neurological disorders (e.g., recent stroke) 2
• Suspected or confirmed pneumonia (requires chest radiography) 2

Common Pitfalls to Avoid

Do not prescribe antibiotics due to patient pressure—clinical criteria must guide prescribing decisions. 2

Recognize that treating uncomplicated viral URTIs with antibiotics exposes patients to unnecessary harm (diarrhea, rash, Clostridium difficile colitis) and contributes to antimicrobial resistance. 1, 2

Most URTIs are self-limited viral infections requiring only symptomatic management—antibiotics are a primary source of antibiotic overuse and misuse in the community. 5